Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI).
Goran PetrovskiFawziya Al KhalafJudith CampbellEmma DayDouha AlmajalyKhalid HussainMaheen PashaFareeda UmerManar HamdanAmel KhalifaPublished in: BMC endocrine disorders (2022)
Children and adolescents with T1D on MDI therapy who initiated the AHCL system following a 10-days structured protocol achieved the internationally recommended goals of glycemic control with TIR > 70% and a HbA1c of < 7%.